好色先生

好色先生

Explore the latest content from across our publications
Join The AAN

Log In

Forgot Password?
Create New Account

Loading... please wait

2025 Annual Meeting | H114 - Clinical Trials Methodology Course (CTMC) (Research Hub)

Monday 04/07/25
01:00 PM - 01:30 PM PDT Add To Calendar
San Diego Convention Center | 11B
This program will be presented both in-person and online
This program will be available in the meeting's On Demand product.
Hubs (Research)
Laurie Gutmann, MD, FAAN, Robin A. Conwit, MD, FAAN, Mark S. Quigg, MD, Christopher Coffey, PhD, FAAN
好色先生, Research, and Methodology, General Neurology
Do you want to improve your clinical trial knowledge? The NINDS Clinical Trials Methodology Course (CTMC) program seeks to train early career investigators to develop scientifically rigorous, feasible, and ethically designed clinical trials, and best practices in trial design from experienced neurological clinical trialists and biostatisticians.   
No CME available
Professionalism, Medical Knowledge, Systems-based Practice
Introductory
Fellow, General Neurologist, Specialist Neurologist, Neurohospitalist
Didactic, Audience Participation

Program Materials

Event Timeline
01:00 PM - 01:30 PM PDT Speaker Clinical Trials Methodology Course (CTMC)
Laurie Gutmann, MD, FAAN, Christopher Coffey, PhD, FAAN, Mark S. Quigg, MD, Robin A. Conwit, MD, FAAN
Faculty Disclosures
Laurie Gutmann, MD, FAAN The institution of Dr. Gutmann has received research support from NIH. The institution of Dr. Gutmann has received research support from Harmony . Dr. Gutmann has received publishing royalties from a publication relating to health care.
Robin A. Conwit, MD, FAAN Dr. Conwit has nothing to disclose.
Mark S. Quigg, MD Dr. Quigg has received personal compensation for serving as an employee of Natus. Dr. Quigg has received personal compensation for serving as an employee of Neurocrine. Dr. Quigg has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Cerebral Therapeutics. Dr. Quigg has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Cerebral Therapeutics. Dr. Quigg has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for Finnigen and Harrison. Dr. Quigg has received research support from NIH. Dr. Quigg has received publishing royalties from a publication relating to health care.
Christopher Coffey, PhD, FAAN Dr. Coffey has received personal compensation in the range of $5,000-$9,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for American Heart Association. The institution of Dr. Coffey has received research support from NIH. The institution of Dr. Coffey has received research support from Michael J Fox Foundation.